Labu holdings.

Please contact [email protected] if you have any further questions. Learn everything about Kelly CRISPR & Gene Editing Technology ETF (XDNA). Free ratings, analyses, holdings, benchmarks, quotes ... Among the largest underlying components of LABU, in trading today ALX Oncology Holdings Inc (NASDAQ:ALXO) is up about 2%, Acadia Pharmaceuticals Inc (NASDAQ:ACAD) is up about 1.5%, and Acceleron Pharma, Inc. is relatively unchanged. For a complete list of holdings, visit the LABU Holdings page »LABU's Structure and Holdings. The LABU ETF primarily invests in derivatives, such as futures, options, and swaps, of companies in the biotech and life sciences sectors.More LABU Holdings Current Portfolio Date Nov 29, 2023 Equity Holdings 133 Bond Holdings 0 Other Holdings 12 % Assets in Top 10 Holdings 18.3 Top 10 Holdings % …AMC AMC ENTERTAINMENT HOLDINGS, INC. ... ‎0.262 ‎-1.20%. GME GAMESTOP CORP. ‎15.39 ‎-6.50%. LABU NYSE ARCA • delayed by 15 minutes • CURRENCY IN USD. Direxion Daily S&P Biotech Bull 3X ...

Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite similar to mutual funds. One unique ETF feature is transparency, allowing investors to see the underlying portfolio securities on a …

LABU cons. The following are LABU weaknesses from our perspective:. LABU net assets are $417.32 million. This fund is not a popular choice with retail investors. LABU 3-year return is -16.34%, which is lower than the 3-year return of the benchmark index (S&P 500 TR USD), 13.64%.Nov 20, 2023 · View the top holdings in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU). Plus view geographic exposure, currency exposure, sector exposure and more.

Hayward Holdings, Inc. 0.16%: 30,141: As of Dec 1, 2023. Showing 50 of 55. Subscribe to see the full list. Start Free Trial. NAIL News. 11 days ago - Top Performing Leveraged/Inverse ETFs: 11/19/2023 - ETF Trends ; 25 days ago - Top Performing Leveraged/Inverse ETFs: 11/05/2023 - ETF Trends ;1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 3.56 Prior Close 3.58 (11/24/23) 1 Day LABU -1.40% …The LABU ETF price gained 3.43% on the last trading day (Wednesday, 29th Nov 2023), rising from $3.50 to $3.62. During the last trading day the ETF fluctuated 7.85% from a day low at $3.55 to a day high of $3.83. The price has risen in 6 of the last 10 days and is up by 12.07% over the past 2 weeks. Volume has increased on the last day …Dec 1, 2023 · $3.46 USD +0.09 (2.67%) Volume: 39,181,706 Zacks ETF Rank NA After-Market: $3.45 -0.01 (-0.29 %) 7:58 PM ET Zacks ETF Categories » » Leveraged Equity ETFs Current Holdings for :: Direxion Daily...

Index Top Ten Holdings % LABU. Direxion Daily S&P Biotech Bull 3X Shares. LABD. Direxion Daily S&P Biotech Bear 3X Shares *The Net Expense Ratio includes management fees, other operating expenses and Acquired Fund Fees and Expenses. If Acquired Fund Fees and Expenses were excluded, the Net Expense Ratio would be 0.95%. The

BIB Description. The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index.

Holdings in LABU have an aggregate rating of Moderate Buy based on 522 analyst ratings issued in the past year covering 41 companies (34.0% of the portfolio). LABU Aggregate Price Target $6.68 59.06% UpsideLABU is diversified through 187 holdings, with the most significant being Madrigal Pharmaceuticals Inc. NASDAQ: MDGL, representing 3.67%, followed by Arrowhead Pharmaceuticals Inc. NASDAQ: ARWR with 1.29% and Cytokinetics Inc. NASDAQ: CYTK at $1.23%. This is designed so that a single company will only impact the fund a little in cases of ...The Direxion Daily S&P Biotech Bull 3X Fund (LABU) is an ETF that seeks to replicate 300% of the daily performance of its benchmark, the S&P Biotechnology Select Industry Index. The fund invests...View Esther Mong David's profile on LinkedIn, the world's largest professional community. Esther Mong has 1 job listed on their profile.LABU cons. The following are LABU weaknesses from our perspective:. LABU net assets are $417.32 million. This fund is not a popular choice with retail investors. LABU 3-year return is -16.34%, which is lower than the 3-year return of the benchmark index (S&P 500 TR USD), 13.64%.; LABU 5-year return is -16.23%, which is lower than the 5-year return …

BIB Description. The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. LABU is diversified through 187 holdings, with the most significant being Madrigal Pharmaceuticals Inc. NASDAQ: MDGL, representing 3.67%, followed by Arrowhead Pharmaceuticals Inc. NASDAQ: ARWR with 1.29% and Cytokinetics Inc. NASDAQ: CYTK at $1.23%. This is designed so that a single company will only impact the fund a little in cases of ...Holdings. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies.LABU: Global X S&P Biotech ETF: ETF: Australia: CURE: Harvest S&P Biotech Slct Sctr ETF (QDII) ETF: China: N/A: Investo S&P Biotech Sel Industry ETF IE: ETF: Brazil: BTEK11: Research & Insights SEE ALL. Commentary - Nov 2, 2023 ; U.S. Equities Market Attributes October 2023LABU : 7.34 (+2.51%) LABU, AADI, ALXO, ABBV: ETF Inflow Alert Dividend Channel - Wed Jan 26, 2022. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Daily S&P Biotech Bull 3X Shares where we have detected an approximate...

Discover historical prices for LABU stock on Yahoo Finance. View daily, weekly or monthly format back to when Direxion Daily S&P Biotech Bull 3X Shares stock was issued.LABU ETF Database Category Average FactSet Segment Average; Number of Holdings 132 111 132 % of Assets in Top 10 40.25% 66.24% 40.25% % of Assets in Top 15 45.09% 70.11% 45.09% % of Assets in Top 50 73.94% 79.10% 73.94%

Oct 27, 2021 · Among the largest underlying components of LABU, in trading today ALX Oncology Holdings Inc (Symbol: ALXO) is down about 1.2%, Acadia Pharmaceuticals Inc (Symbol: ACAD) is down about 0.7%, and ... LABU cons. The following are LABU weaknesses from our perspective:. LABU net assets are $417.32 million. This fund is not a popular choice with retail investors. LABU 3-year return is -16.34%, which is lower than the 3-year return of the benchmark index (S&P 500 TR USD), 13.64%.View the top holdings in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU). Plus view geographic exposure, currency exposure, sector exposure and more. ... Top 50 LABU Holdings. Rank Company Current Price Weight Shares Held; 1: Dreyfus Govt Cash Man Ins: N/A: 15.07%: 153,587,408: 2: Goldman Sachs Sterling …Direxion Daily S&P Biotech Bear 3X Shares ETF holdings by MarketWatch. View complete LABD exchange traded fund holdings for better informed ETF trading.3 thg 8, 2023 ... New 2-sty Terrace/Link House for sale at Tiara Sendayan, Labu by Matrix Concepts Holdings Berhad. View the project information and ...The precise amount of antifreeze a radiator holds depends upon the size and make of the car, but the solution in a car radiator should be a mix of about 50 to 60 percent antifreeze and 40 to 50 percent water.

0.82%. ARKK, ARK Innovation ETF, 0.36%. LABU, S&P Biotech Bull 3X Shares ETF, 0.124%. IBB, iShares Biotechnology ETF, 0.07%. 1. Research Notes and Commentary ...

Among the largest underlying components of LABU, in trading today ALX Oncology Holdings Inc (Symbol: ALXO) is down about 1.2%, Acadia Pharmaceuticals Inc (Symbol: ACAD) is down about 0.7%, ...

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and ... I don’t suggest holding either LABU or LABD-at least for any period longer than a few days. There would be an exception if, say, you bought 100 shares and sold 5 calls.Dec 1, 2023 · About LABU. Fund Home Page. The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is issued by Direxion. Asset Class Equity. Heather Bell | Mar 28, 2016. Learn everything about Direxion Daily S&P Biotech Bull 3X Shares (LABU). Free ratings, analyses, holdings, benchmarks, quotes, and news. Laba Holdings Ltd. Portion 152 Papa-Lealea Rd Hiri West. PO Box 296 Boroko. +675 7090 8300 [email protected] www.laba.com.pg.TECS. The Direxion Daily Technology Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the Technology Select Sector Index. There is no guarantee the funds will achieve their stated investment objectives.LABU is an exchange-traded fund (ETF) that aims to triple the daily return of the S&P Biotechnology Select Industry Index, a benchmark for the biotechnology sector. Learn more about the fund's portfolio composition, holdings, risks, and performance on Fidelity. About LABU. Fund Home Page. The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is issued by Direxion. Asset Class Equity.LABU is an exchange-traded fund (ETF) that aims to triple the daily return of the S&P Biotechnology Select Industry Index, a benchmark for the biotechnology sector. Learn more about the fund's portfolio composition, holdings, risks, and performance on Fidelity. See the company profile for Direxion Daily S&P Biotech Bull 3X Shares (LABU) including business summary, industry/sector information, number of employees, business summary, corporate governance ...Find the latest Direxion Daily S&P Biotech Bull 3X Shares (LABU) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

0.82%. ARKK, ARK Innovation ETF, 0.36%. LABU, S&P Biotech Bull 3X Shares ETF, 0.124%. IBB, iShares Biotechnology ETF, 0.07%. 1. Research Notes and Commentary ...Basic Info. The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ...Jun 2, 2023 · Objective. The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs ... Instagram:https://instagram. high leverage brokerstrucking companies stocksarm stock price today per sharelithium ion battery companies stock Holdings. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Unlock comprehensive insights, track … mortgage lender michigansly etf The National, Thursday September 17th, 2015. LANDOWNER companies from the Labu and Ahi villages of Lae have joined forces to create a new joint-venture company. The two companies, Labu Holdings Ltd and Ahi Holdings Ltd, have formed a new JV called Morobe International Terminal Ltd to bid for terminal management at the …LABU cons. The following are LABU weaknesses from our perspective:. LABU net assets are $417.32 million. This fund is not a popular choice with retail investors. LABU 3-year return is -16.34%, which is lower than the 3-year return of the benchmark index (S&P 500 TR USD), 13.64%.; LABU 5-year return is -16.23%, which is lower than the 5-year return … cambpell soup View Top Holdings and Key Holding Information for ProShares UltraPro Short QQQ (SQQQ).In total, we count 52 funds holding LABU within the last two filing periods in our coverage universe of 13F filers, with the largest position size having been reported by Squarepoint Ops LLC. For more details on the positions held by Squarepoint Ops LLC (or by any of the other funds holding LABU), click the fund name in the "Holder" column of the funds …